Ensuring patients have access to needed medicines is critical, but the importation of unapproved medicines, from Canada or elsewhere in the world, poses a serious risk to public health.

The U.S. Food and Drug Administration (FDA) is the gold standard when it comes to reviewing and approving drugs. Medicines that enter the United States through importation will not be subject to these same strong standards and, as a result, counterfeit, substandard or diverted, repackaged and adulterated drugs could be introduced into our secure drug supply chain.